Cargando…
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been redetected after discharge in some coronavirus disease 2019 (COVID-19) patients. The reason for the recurrent positivity of the test and the potential public health concern due to this occurrence are still unknown. Here, we analyz...
Autores principales: | Hu, Fengyu, Chen, Fengjuan, Ou, Zhihua, Fan, Qinghong, Tan, Xinghua, Wang, Yaping, Pan, Yuejun, Ke, Bixia, Li, Linghua, Guan, Yujuan, Mo, Xiaoneng, Wang, Jian, Wang, Jinlin, Luo, Chun, Wen, Xueliang, Li, Min, Ren, Peidi, Ke, Changwen, Li, Junhua, Lei, Chunliang, Tang, Xiaoping, Li, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546387/ https://www.ncbi.nlm.nih.gov/pubmed/33037400 http://dx.doi.org/10.1038/s41423-020-00550-2 |
Ejemplares similares
-
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
por: Feng, Chengqian, et al.
Publicado: (2021) -
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China
por: Lei, Chunliang, et al.
Publicado: (2020) -
Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19
por: He, Xi, et al.
Publicado: (2020) -
A Case of New Variant COVID-19 First Emerging in South Africa Detected in Airplane Pilot — Guangdong Province, China, January 6, 2021
por: Chen, Fengjuan, et al.
Publicado: (2021) -
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
por: Li, Yueping, et al.
Publicado: (2020)